Jörg Janne Vehreschild

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik et al. · Cell · 2020 · 1.6K citations · Full text

Covid-19 Pandemic, Hematology, Pathology +6

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

Adam Trickey, Margaret May, Jörg Janne Vehreschild et al. · The Lancet HIV · 2017 · 1.1K citations · Full text

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

Frederikus A. Klok, Gudula J.A.M. Boon, Stefano Barco et al. · European Respiratory Journal · 2020 · 685 citations · Full text

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 676 citations

Single-arm Open-label Trial, Antifungal Agent, Antifungal Agents +4

Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

Joana P. Bernardes, Neha Mishra, Florian Tran et al. · Immunity · 2020 · 400 citations · Full text

Erythroid Cells, Long Covid, Immunology +4